Profile
Corporate information
Official name
InterAx Biotech AG
Official name
InterAx Biotech AG
Investment activity status
Active investor
Overview
InterAx Biotech AG is a spinoff from ETH Zurich and the Paul Scherrer Institute. InterAx has built a unique drug discovery platform for identification of superior drug candidates. This technology allows for the integration of both, experimental and computational pharmacology, and is able to predict in vivo effects of drug candidates by analyzing complex experimental in vitro data sets.
Funding
Funding rounds
Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Verve Capital Partners AG | Switzerland | Initial investment. Round participant. |
Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Falcon Ventures | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Round | |
|---|---|---|
|
|
AKB |
N/A |
|
|
Falcon Ventures |
N/A |
|
|
Verve Capital Partners AG |
N/A |